A total of five drugs, Acetaminophen, Estradiol, Cyclosporine, Calcitriol, and Seocalcitol (Table 1), demonstrated the capability to potentially reduce the expression levels of OAS1, OAS2, OAS3, and OASL, suggesting their prospective use in breast cancer treatment. This evidence concerns the gene OAS2 and breast carcinoma.